N-[(2-DIMETHYLAMINO)-ETHYL]-4-[2-(5-METHYL-2-METHYLSULFANYL-6-OXO-1,6-DIHYDROPYRIMIDIN-1-YL)-ETHYL]-ISOXAZOLE-3-CARBOXAMIDE
Compound with spectra: 1 NMR
![N-[(2-DIMETHYLAMINO)-ETHYL]-4-[2-(5-METHYL-2-METHYLSULFANYL-6-OXO-1,6-DIHYDROPYRIMIDIN-1-YL)-ETHYL]-ISOXAZOLE-3-CARBOXAMIDE](/api/compound/K6xMAzhbg1x.png?ph=true&h=300&w=458 "N-[(2-DIMETHYLAMINO)-ETHYL]-4-[2-(5-METHYL-2-METHYLSULFANYL-6-OXO-1,6-DIHYDROPYRIMIDIN-1-YL)-ETHYL]-ISOXAZOLE-3-CARBOXAMIDE")
| SpectraBase Compound ID | K6xMAzhbg1x |
|---|---|
| InChI | InChI=1S/C16H23N5O3S/c1-11-9-18-16(25-4)21(15(11)23)7-5-12-10-24-19-13(12)14(22)17-6-8-20(2)3/h9-10H,5-8H2,1-4H3,(H,17,22) |
| InChIKey | LXCOFUGZVPHSBI-UHFFFAOYSA-N |
| Mol Weight | 365.45 g/mol |
| Molecular Formula | C16H23N5O3S |
| Exact Mass | 365.152161 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
2,3-dihydro-5-oxo-5H-thiazolo[3,2-a]pyrimidine-6-carboxylic acid, p-methoxyphenyl ester
2,3-dihydro-5-oxo-5H-thiazolo[3,2-a]pyrimidine-6-carboxylic acid, p-fluorophenyl ester
1-[(2,3-dihydro-5-oxo-5H-thiazolo[3,2-a]pyrimidin-6-yl)carbonyl]-4-(p-fluorophenyl)-3-thiosemicarbazide
3-Allyl-5-(4-bromobenzoyl)-2-(methylthio)pyrimidin-4(3H)-one
7-butyl-8-hydroxy-3,4-dihydro-2H,6H-pyrimido[2,1-b][1,3]thiazin-6-one
6-(3-Nitrobenzyl)-5H-thiazolo[3,2-a]pyrimidin-5-one
2-({(4E)-1-(3-methoxypropyl)-4-[(1-methyl-1H-pyrazol-4-yl)methylene]-5-oxo-4,5-dihydro-1H-imidazol-2-yl}sulfanyl)acetamide
2-(1-benzyl-4-benzylidene-5-oxo-imidazol-2-yl)sulfanylacetamide
5H-Thiazolo[3,2-a]pyrimidin-5-one, 6-(4-morpholinylcarbonyl)-
3-Benzyl-5-benzylidene-2-hexylsulfanyl-imidazol-4-one
| Title | Journal or Book | Year |
|---|---|---|
| 1,3-Dipolar cycloaddition approach to the construction of new bis-heterocycles from thymine as potential non-nucleoside reverse transcriptase inhibitors | Journal of the Chemical Society, Perkin Transactions 1 | 1997 |